|
| Welcome to Biochempartner |
| BCP0001 |
GDC-0941 |
| GDC-0941 is a potent inhibitor of PI3K¦Á, PI3K¦Â, PI3K¦Ä and PI3K¦Ã ;10G in stock |
| BCP0002 |
GDC0449(Vismodegib) |
| GDC-0449 is a more potent and specific synthetic oral SMO inhibitor,20G in stock |
| BCP0003 |
GDC-0879 |
| A highly selective,orally bioavailable B-Raf inhibitor. |
| BCP0004 |
Gefitinib |
| Gefitinib was found to be a potent inhibitor of EGFR kinase. |
| BCP0005 |
Gemcitabine Hydrochloride |
| A new pyrimidine antimetabolite which has shown good clinical activ.A nucleoside analog of deoxycytidine used in chemotherapy to treat various types of cancer. |
| BCP0006 |
GSK1904529A |
| GSK1904529A is a selective inhibitor of IGF-IR and IR with IC50 of 27 nM and 25 nM, respectively. |
| BCP0007 |
GSK461364 |
| GSK461364 is an ATP-competitive inhibitor of Plk1 and forms a rapidly reversible complex with Plk1. |
| BCP0008 |
GSK690693 |
| aminofurazan-derived inhibitor of Akt kinases with potential antine |
| BCP0010 |
ABT-263(Navitoclax) |
| ABT-263 (Navitoclax) is a potent orally bioavailable SMI that is structurally related to ABT-737. ABT-263 disrupts Bcl-2 - Bcl-XL interactions with pro-apoptotic proteins . |
|
ShangHai Biochempartner Co.,Ltd.
Tel:0086-400-021-9906
Mobile::0086-18672933340
E-mail:orders@biochempartner.com
Skype: |
|
